ACTR-79. ESTABLISHMENT OF CLINICAL PROTOCOL TARGETING CANCER STEM CELLS IN RECURRENT GLIOBLASTOMA USING HIGH-THROUGHPUT DRUG SCREENING

Despite aggressive multimodal oncological treatment, glioblastoma (GBM) disease progresses within 10 months. Due to the lack of treatment options for the relapsed disease, enrollment in clinical trials may be the best option. However, the fundamental preclinical studies leading to clinical investiga...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Neuro Oncol
Huvudupphovsmän: Skaga, Erlend, Kulesskiy, Evgeny, Brynjulfsen, Marit, Sandberg, Cecilie Jonsgar, Kyttälä, Aija, Langmoen, Iver Arne, Laakso, Aki, Gaál-Paavola, Emília, Perola, Markus, Wennerberg, Krister, Vik-Mo, Einar Osland
Materialtyp: Artigo
Språk:Inglês
Publicerad: Oxford University Press 2017
Ämnen:
Abstracts
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5692302/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.066
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk